Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10008688HBVENSG00000116678.20protein_codingLEPRNoNo3953P48357
Q4G138
TVIS10048250HBVENSG00000116678.20protein_codingLEPRNoNo3953P48357
Q4G138
TVIS10042539HBVENSG00000116678.20protein_codingLEPRNoNo3953P48357
Q4G138
TVIS10043977HBVENSG00000116678.20protein_codingLEPRNoNo3953P48357
Q4G138
TVIS10040517HBVENSG00000116678.20protein_codingLEPRNoNo3953P48357
Q4G138
TVIS30023981HIVENSG00000116678.20protein_codingLEPRNoNo3953P48357
Q4G138
TVIS20026908HPVENSG00000116678.20protein_codingLEPRNoNo3953P48357
Q4G138
TVIS20024795HPVENSG00000116678.20protein_codingLEPRNoNo3953P48357
Q4G138
TVIS20045798HPVENSG00000116678.20protein_codingLEPRNoNo3953P48357
Q4G138
TVIS20014049HPVENSG00000116678.20protein_codingLEPRNoNo3953P48357
Q4G138
TCGA Plot Options
Drug Information
GeneLEPR
DrugBank IDDB09046
Drug NameMetreleptin
Target IDBE0003376
UniProt IDP48357
Regulation Typeagonist
PubMed IDs25249580
CitationsMoon HS, Huh JY, Dincer F, Schneider BE, Hasselgren PO, Mantzoros CS: Identification and saturable nature of signaling pathways induced by metreleptin in humans: comparative evaluation of in vivo, ex vivo, and in vitro administration. Diabetes. 2015 Mar;64(3):828-39. doi: 10.2337/db14-0625. Epub 2014 Sep 23.
GroupsApproved
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBLCHEMBL2107857